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Abstract
OBJECTIVES—To determine the relationship between frailty and overall and cardiovascular 
mortality.
DESIGN—Longitudinal mortality analysis.
SETTING—National Health and Nutrition Examination Survey (NHANES) 1999–2004.
PARTICIPANTS—Community-dwelling older adults aged 60 and older (N = 4,984; mean age 
71.1 ± 0.19, 56% female).
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MEASUREMENTS—We used data from 1999–2004 cross-sectional NHANES and mortality 
data from the National Death Index, updated through December 2011. An adapted version of 
Fried’s frailty criteria was used (low body mass index, slow walking speed, weakness, exhaustion, 
low physical activity). Frailty was defined as persons meeting 3 or more criteria, prefrailty as 
meeting 1 or 2 criteria, and robust (reference) as not meeting any criteria. The primary outcome 
was to evaluate the association between frailty and overall and cardiovascular mortality. Cox 
proportional hazard models were used to evaluate the association between risk of death and frailty 
category adjusted for age, sex, race, smoking, education, coronary artery disease, heart failure, 
nonskin cancer, diabetes, and arthritis.
RESULTS—Half (50.4%) of participants were classified as robust, 40.3% as prefrail, and 9.2% as 
frail. Fully adjusted models demonstrated that prefrail (hazard ratio (HR) = 1.64, 95% confidence 
interval (CI) = 1.45–1.85) and frail (HR = 2.79, 95% CI = 2.35–3.30) participants had a greater 
risk of death and of cardiovascular death (prefrail: HR = 1.84, 95% CI = 1.45–2.34; frail: HR = 
3.39, 95% CI = 2.45–4.70).
CONCLUSION—Frailty and prefrailty are associated with increased risk of death. 
Demonstrating the association between prefrail status and mortality is the first step to identifying 
potential targets of intervention in future studies.
Keywords
frailty; prefrailty; mortality; cardiovascular
Frailty is a decline in the body’s physiological reserve and a reduced ability to maintain 
homeostasis among life’s constant stressors.1 It has been associated with functional losses, 
disability, greater healthcare use, and higher healthcare costs.2–7 Although a standardized 
definition of frailty has not been agreed upon, its concept has evolved to be a complex 
relationship of physical, psychological, and social factors.7 Fried’s landmark study 
demonstrated a way to operationalize frailty collectively as a phenotype defined according to 
a set of variables: unintentional weight loss, self-reported exhaustion, slow gait speed, low 
energy expenditure and weak grip strength (frail ≥3; prefrail 2).8 By this definition the 
prevalence of frailty is estimated to be 10.7% while prefrailty is 41.6% in community-
dwelling older adults.9 It is thought that prefrailty has similar associations with the negative 
outcomes of frailty. As frailty is a dynamic process, prefrail individuals are more likely to 
maintain prefrail status or revert back to a robust state than frail individuals.10 This makes 
prefrailty an intermediary, possibly reversible phase that should be investigated separately 
from frailty in its associations and potential interventions.
Frailty is a known risk factor for mortality.11–14 A metaanalysis demonstrated 50% greater 
mortality in individuals with frailty than in robust subjects and that this risk escalates with 
each additional phenotypic frailty component.15 Frailty is also thought to have quadruple the 
risk of cardiovascular mortality,16 but evidence of prefrailty’s association with overall and 
cardiovascular mortality is less clear, with conflicting studies demonstrating various 
relationships between prefrailty and survival. The aim of this study was to evaluate mortality 
in prefrail individuals to determine whether it is an important entity in itself. We 
Crow et al. Page 2
J Am Geriatr Soc. Author manuscript; available in PMC 2018 March 14.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
hypothesized that the risk of all-cause and cardiovascular death in prefrail individuals would 
be significantly greater than robust participants.
METHODS
Study Design and Participants
Participants included in the analysis were identified from the 1999 to 2004 cross-sectional 
National Health and Nutrition Survey (NHANES). NHANES is a multistage probability 
survey conducted by the National Center for Health Statistics designed to assess the health 
and nutritional status of adults and children in the United States. The survey focuses on 
noninstitutionalized persons and oversamples non-Hispanic blacks, Mexican Americans, and 
persons aged 60 and older. Full details are available at http://www.cdc.gov/nchs/
nhanes.html.
The total sample in NHANES consisted of 38,077 participants. Of these, 29,402 were 
interviewed and examined in a mobile examination center. We aimed to include only those 
aged 60 and older (n = 7,729) who had full body composition data (n = 4,984) in our 
secondary analysis. Trained field staff interviewed participants in English or Spanish, and 
data collection was automated. Respondents completed questionnaires directly or, if unable, 
by proxy. The local institutional review board at Dartmouth college exempted this study 
from review because of the de-identified nature of the data.
Mortality Data
Mortality was evaluated using the 2015 public-use linked mortality files, which include 
mortality data from the time of the study through December 31, 2011. These data were 
obtained from the National Death Index, a service of the National Center for Health 
Statistics that serves as a centralized database of death record information in state vital 
statistics offices. These data are linked to the NHANES data using a unique study identifier. 
Full details are available at https://www.cdc.gov/nchs/ndi/index.htm. Time to death was 
calculated in days from the date of death, and overall and cardiovascular mortality were 
assessed. Cardiovascular mortality was defined using International Classification of Disease 
codes.
Study Variables
We applied the Fried definition of frailty to our study sample using data from participant 
self-reported questionnaires and objective measures. The 5 criteria of frailty from the 
Cardiovascular Health Study8,17 were adapted, as has been done previously with NHANES 
data18: unintentional weight loss of 10 pounds or more in a year: low body mass index 
(BMI)<18.5 kg/m2; self-reported exhaustion: difficulty walking between rooms; weakness: 
difficulty lifting or carrying 10 lbs; slow walking speed: gait speed <0.8 m/s; and low 
physical activity: reduced physical activity compared to others your age. Frailty was defined 
as meeting 3 or more of the five criteria, prefrailty as meeting 1 or 2 criteria, and robust as 
meeting 0 of the 5 criteria.
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Covariates
Demographic variables included self-reported age, sex, race, marital status, education, 
smoking status, and ethnicity. We categorized respondents as non-Hispanic white, non-
Hispanic black, Hispanic, or other. We ascertained self-reported comorbidities such as 
diabetes, arthritis, coronary artery disease, congestive heart failure, and non-skin cancer if 
participants answered the question “Has a doctor ever told you have [disease state]?” 
Participants were classified as smokers if they had smoked at least 100 cigarettes in their 
lifetime.
Weight was measured in kilograms on an electronic digital scale. Height was measured 
using a stadiometer. Subjects were asked a number of self-perception questions regarding 
limitations in activities of daily living (ADLs) and instrumental activities of daily living 
(IADLs). All activities were self-reported, and subjects noted on scale from 1 to 4 their 
degree of difficulty in performing these tasks. We classified subjects as having difficulty if 
they indicated a response of anything other than “no difficulty.” Of the 7 well-accepted 
IADLs,19 NHANES included managing money, performing household chores, preparing 
meals, and handling routine needs. We defined ADL disability as difficulty getting in and 
out of bed or inability to dress or eat. NHANES did not include assessment of bathing or 
toileting.20
Statistical Analysis
All data were merged into one file for this analysis. All analyses accounted for the complex, 
stratified nature of NHANES and incorporated primary sampling units, weighting, and 
strata, according to analytical guidelines. Continuous variables are represented as means and 
standard errors and categorical variables as counts and weighted percentages. Analysis of 
variance and chi-square tests were used to assess differences in baseline characteristics 
according to frailty group. Because gait speed was not assessed in NHANES 2003–04, we 
used multiple imputation analyses to account for missing values. Multiple imputations were 
conducted using R version 3.3.2 and the package mice, which operates by creating plausible 
data values from a distribution specifically designed for each data point. We generated 5 
imputed data sets using predictive mean matching. The correction variables used were age, 
sex, education, protein, race, diabetes, arthritis, congestive heart failure, cancer, and lean 
mass percentage. The 5 data sets were averaged, resulting in a final imputed data set used for 
analysis. To test the quality of the imputation, analyses were run on the full imputed data set 
and on a subset excluding the imputed variables.
The primary outcome was mortality risk, and the primary predictor was frailty category. 
Three separate Cox proportional hazard models were created to evaluate the risk of death. 
Model 1 was unadjusted and included frailty categories as the sole predictors; Model 2 
included age, sex, race, education, and smoking; and Model 3 included the covariates in 
Model 2 and additionally adjusted for comorbidities such as diabetes, heart failure, cancer, 
coronary artery disease, and arthritis. All-cause and cardiovascular mortality were assessed 
and are presented in the results as hazard ratios (HRs) with 95% confidence intervals (CIs). 
Kaplan-Meier survival curves for overall and cardiovascular mortality are presented in 
Figure 1. As an exploratory analysis, mortality modeling was stratified according to age 
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group (60–69, 70–79, ≥80). As a comparison to our imputed gait speed model, frailty rates 
were calculated using a 4-component model by removing the gait speed criteria: robust 
meeting 0 criteria, prefrail meeting 1–2 criteria, frail meeting 3–4 criteria. The above models 
were replicated (not shown). Data analysis was conducted using Stata version 12 (Stata 
Corp., College Station, TX). P < .05 was considered statistically significant.
RESULTS
The mean age of the selected study sample of 4,984 participants was 71.1 ± 0.19, and they 
had a mean BMI of 28.2 ± 0.10 kg/m2. The majority of the participants were non-Hispanic 
white (Table 1). Participants with higher frailty status were more likely to be female, have a 
higher BMI, and be older. Frail and prefrail participants were more likely to have concurrent 
comorbidities such as diabetes, coronary artery disease, arthritis, stroke, chronic kidney 
disease, and chronic obstructive pulmonary disease and significantly more likely to have 
dysfunction in at least one IADL or ADL. There were few observed differences in baseline 
characteristics between those with complete frailty variable data and those without complete 
frailty data. Those with incomplete data were slightly older, had lower BMI, and more ADL 
and IADL limitations at baseline (Table S1).
Table 2 presents a breakdown of each frailty component; the number of components 
participants in the study fulfilled; and overall rates of participants who were robust, prefrail, 
and frail. Robust and frail rates differed between our 5- and 4-component models mostly at 
the extremes, with 50.4% and 65.4% classified as robust and 9.2% and 4.5% as frail, 
respectively. The frailty component seen at the highest rate was low walking speed (31.3%), 
followed by weakness (27.1%). Few participants met all 5 criteria (<1%).
Over the course of follow-up 1,901 participants died, with 521 (27.4%) dying from 
cardiovascular causes. Median follow-up time was 95.8 months (interquartile range 78–124). 
Overall and cardiovascular mortality analyses along the frailty spectrum are outlined in 
Table 3. The adjusted models suggest a 64% higher mortality rate (HR = 1.64, 95% CI = 
1.45–1.85) in prefrail individuals than in those who were robust and a rate nearly 3 times as 
high in frail individuals (HR = 2.79, 95% CI = 2.35–3.30). Similar estimates were observed 
for cardiovascular mortality (prefrail: HR = 1.84, 95% CI = 1.45–2.34; frail: HR = 3.39, 
95% CI = 2.45–4.70). Figures 1 and 2 depict the Kaplan Meier survival curves for overall 
mortality and cardiovascular mortality. As an exploratory analysis, we stratified trail 
participants mortality rates according to age group (Table S2). Prefrailty rates and overall 
mortality according to age group demonstrated a trend toward greater risk than robust for all 
geriatric age groups (60–69: HR = 1.65, 95% CI = 1.31–2.09; 70–79: HR = 1.77, 95% CI = 
1.45–2.17; ≥80: HR = 1.57, 95% CI = 1.28–1.92). We found similar results examining 
prefrailty and cardiovascular mortality compared to robust (60–69: HR = 1.52, 95% CI = 
0.95–2.44; 70–79: HR = 2.42, 95% CI = 1.61–3.65; ≥80: HR = 1.88, 95% CI = 1.25–2.81).
DISCUSSION
This study demonstrates that, although frailty has a larger association with overall and 
cardiovascular mortality than prefrailty, the association between prefrailty and mortality is 
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meaningful and noteworthy. Specifically, prefrail participants were 64% more likely than 
robust participants to die.
Few studies have focused on the relationship between prefrailty and mortality. A systematic 
review15 evaluating the association between mortality and frailty did not examine the 
relationship specifically with prefrailty. The Cardiovascular Health Study demonstrated the 
relative risk of mortality in prefrail individuals over a 4 year time period to be 1.67, (95% CI 
= 1.29–2.15),17 and another study21 that evaluated men aged 65 and older found prefrail 
participants were 36% more likely to die than robust individuals. Other studies such as the 
Crystal study22 and The Three-City Study6 challenge this association, with their findings 
failing to show statistically significant greater mortality in prefrail participants, making this 
relationship unclear.
Evidence for a strong association between frailty and cardiovascular disease exist while 
prefrailty’s relationship is less defined.11,23–26 The Progetto Veneto Anziani Study found 
that low energy expenditure, exhaustion, and slow gait speed were predictive of new 
cardiovascular events, and prefrailty appeared to be an independent predictor of 
cardiovascular disease.25 A metaanalysis examining the relationship between frailty and 
mortality found that prefrail participants were 3 times as likely to die from cardiovascular 
disease over a median 4.4-year follow-up,16 although that analysis was based on 2 studies 
not representative of community-dwelling elderly adults; one focused on posthospital 
discharge mortality after a myocardial infarction,24 and the other evaluated individuals 
without baseline cardiovascular disease.25
Determining this association is important in clarifying prefrailty as an important diagnostic 
entity in itself versus another early disease state. Although some preconditions such as 
prehypertension have been well defined, no association has been found between 
prehypertension and overall mortality.27 This is unlike other precondition states such as 
prediabetes, for which a metaanalysis demonstrated an associated greater risk of all-cause 
and cardiovascular mortality when defined according to fasting glucose as low as 5.6 
mmol/L.28 This demonstrates that not all preconditions are equal in their associated risks.
Another important argument for early recognition of prefrailty outside its own associated 
risks is its higher likelihood of reversibility. One study of the transitions of frailty found that 
57.6% of participants had at least one transition in the 54-month follow-up.10 Transition to 
greater frailty was 43.3%, versus 23% to less frailty. Rates of transition from frail to robust 
were negligible (≤0.9%), and the longer participants were classified as frail, the greater their 
chance of remaining frail and the higher their mortality, but if participants entered the study 
prefrail, the chances of remaining prefrail or transitioning to robust over 36 months was 
78.4%. Those starting prefrail had higher rates of transitioning back to robust in the first 36 
months, although chances were lower, and mortality was greater for those remaining prefrail 
over this 54-month period. This demonstrates that recognizing prefrailty and intervening 
reduces not only the chances of frailty progression, but also the higher mortality risk of 
remaining prefrail.
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Our study of a large, nationally representative sample provides further support for a 
significant association between mortality and prefrailty. These results highlight the 
importance of identifying individuals across the frailty spectrum. Few studies have explored 
the most mutable risk factors aimed at preventing transitions to higher frailty states. One 
trial29 assessed the effect of an exercise and nutritional intervention on quality of life and 
physical performance over 12 weeks in prefrail women. Significant improvements in 
handgrip strength, subjective pain, and emotional well-being with exercise were observed 
but not maintained at 6-month follow-up. A larger study, the Lifestyle Interventions and 
Independence for Elders Pilot Study,30 completed over 12 months, examined older adults at 
risk of disability and demonstrated that 150 min/wk of activity plus balance training led to 
faster walking speed. These studies indicate that interventions can reverse prefrailty, but 
studies showing maintenance of these benefits over time are lacking.
Our study had a number of strengths, including large sample size and use of self-reported 
and biometric measurements and of a validated tool for frailty classification, which makes 
our findings relevant. Or study also had several important limitations. First, the variables 
present in NHANES to operationalize Fried’s frailty criteria required us to modify some of 
the original definitions, but the prevalence rates of each component were comparable with 
those in other studies.8,15,31 Second, because walking speed was missing for 3,645 
participants, we performed multiple imputations to maximize our data analysis. We used 
multivariate imputation by chained equations for our missing data, a robust method that 
generates multiple predictions for each missing value, taking the uncertainty of the 
imputations into account and yielding accurate standard errors.32 We did not use data 
without imputed gait speed for conclusion data, but baseline characteristics of those with 
gait speed information were compared with characteristics of those with imputed gait speed 
to show that they were similar populations. Third, a number of the frailty components are 
based on self-reported data and are subject to recall bias. Fourth, although we demonstrated 
greater mortality risk by age, we caution the reader on generating conclusions from this data 
because of the sample sizes in the age subgroups. Because our study sample included only 
community-dwelling adults, this could have led to some selection bias, particularly for those 
aged 80 and older, which probably made our results more conservative than if 
institutionalized elderly adults had been included. Also, because of the increasing literature 
on the association between valvular heart disease and frailty, we caution the reader on the 
limitation of our dataset to correct for this variable in our analysis.33,34 In addition, medical 
care and culture have changed since early the 2000s, and mortality rates continue to decline 
from heart disease, stroke, and cancer, whereas diabetes and obesity rates have increased, 
according to several U.S. studies.35,36 The decline in rates cardiovascular mortality seems to 
have slowed, probably because of incremental advances in prevention and treatment, along 
with the increasing aging population’s high on rates of heart disease and mortality.37,38 A 
limitation in Fried’s frailty model is its lack of cognitive and psychosocial factors in 
determining frailty status. There is increasing evidence that inclusion of these factors could 
improve predictive ability for adverse health outcomes.39 The deficit accumulation model 
that Rockwood and colleagues defined encompasses cognitive changes as part of defining 
frailty. Although frailty rates vary according to definition (9.9% for physical frailty and 
13.6% for physical and psychosocial frailty),9 when evaluating mortality, as we aimed to do 
Crow et al. Page 7
J Am Geriatr Soc. Author manuscript; available in PMC 2018 March 14.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
here, both models have shown comparable results.40,41 Lastly, with any epidemiology-based 
analysis, causality cannot be inferred, and future longitudinal, interventional studies are 
needed.
The large number of prefrail and frail individuals will continue to grow as our society 
continues to age.42 Prefrailty and frailty should be ascertained because an estimated 3% to 
5% of deaths of older adults could be delayed with frailty prevention.43 The implementation 
of interventions targeting the most common deficits in the frailty spectrum (gait speed and 
weakness) has a large potential to improve function: reduce hospitalization, 
institutionalization, and unneeded healthcare spending while improving quality of life.8,15,26 
Recognizing prefrailty as its own entity is essential because of its association with overall 
and cardiovascular mortality, as well as its window of opportunity for reversibility in 
delaying frailty progression. Knowledge of prefrailty’s association of mortality allows 
providers to see the value of aggressive primary and secondary prevention through 
optimizing medication management and health promotion efforts. With this relationship 
known, research efforts can examine potential interventions and their ability to improve 
long-term outcomes.
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Figure 1. 
Kaplan Meier survival curve for (A) all-cause and (B) cardiovascular mortality of robust, 
prefrail, and frail participants demonstrating a significant trend toward greater death from 
all-cause and cardiac causes with greater frailty status.
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Table 2
Frailty Components and rates
Frailty Components
Five-Component Model Four-Component Modela
n (weighted %)
Difficulty walking between rooms    586 (10.0)
Body mass index <18.5 kg/m2      59 (1.3)
Less activity than peers    735 (14.1)
Gait speed <0.8 m/sb 1,865 (31.3)        n/a
Difficulty lifting 10 pounds 1,455 (27.1)
Number of components
 0 2,246 (50.4) 3,063 (67.0)
 1 1,486 (27.7) 1,026 (21.7)
 2    709 (12.6)    414 (7.8)
 3    371 (6.4)    189 (3.4)
 4    167 (2.7)        5 (0)
 5        3 (0)        n/a
Frailty status
 Robust 2,246 (50.4) 3,158 (65.4)
 Prefrail 2,195 (40.3) 1,561 (30.2)
 Frailty    541 (9.2)    263 (4.5)
a
Defining frailty according to 4-component model: robust = 0 criteria, prefrail = 1–2 criteria, frailty = 3–4 criteria.
b
Imputed and nonimputed.
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Table 3
Association Between Frailty and Overall and Cardiovascular Mortality
Mortality
Model 1 Model 2 Model 3
Hazard Ratio (95% Confidence Interval)
Overall
 Prefrail 2.40 (2.16–2.67) 1.79 (1.60–2.01) 1.64 (1.45–1.85)
 Frail 4.97 (4.34–5.69) 3.89 (3.36–4.51) 2.79 (2.35–3.30)
Cardiovascular
 Prefrail 2.82 (2.28–3.48) 2.07 (1.65–2.60) 1.84 (1.45–2.34)
 Frail 3.72 (2.85–4.87) 4.79 (3.61–6.34) 3.39 (2.45–4.70)
Model 1: unadjusted.
Model 2: adjusted for age, sex, race, education, smoking.
Model 3: adjusted for Model 2 covariates and diabetes, heart failure, cancer, coronary artery disease, arthritis.
Reference: robust.
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